Regeneron Pharmaceuticals Inc government contracts
$984M obligated across 3 federal awards. 2 are still running.
Who buys from Regeneron Pharmaceuticals Inc
| Agency | Awards | Obligated |
|---|---|---|
| Office of Assistant Secretary for Preparedness and Response | 3 | $984M |
What Regeneron Pharmaceuticals Inc sells
Its awards by NAICS code. Codes with live notices link to them.
| Industry | Awards | Obligated |
|---|---|---|
| NAICS 541711 NAICS 541711 | 3 | $984M |
Contracts ending soon
Awards that end in the next 18 months, soonest first. Expiring work is often recompeted.
| Award | Obligated | Start | End |
|---|---|---|---|
| IGF::OT::IGF - REGENERON OTHER TRANSACTION AUTHORITY (OTA) AWARD Office of Assistant Secretary for Preparedness and Response · HHSO100201700020C | $280M | Sep 21, 2017 | Sep 24, 2027 |
| IGF::OT::IGF Office of Assistant Secretary for Preparedness and Response · HHSO100201700016C | $696M | Sep 30, 2017 | Sep 29, 2027 |
Largest awards
By total obligated value. Each links to its record on USAspending.gov.
| Award | Obligated | Start | End |
|---|---|---|---|
| IGF::OT::IGF Office of Assistant Secretary for Preparedness and Response · HHSO100201700016C | $696M | Sep 30, 2017 | Sep 29, 2027 |
| IGF::OT::IGF - REGENERON OTHER TRANSACTION AUTHORITY (OTA) AWARD Office of Assistant Secretary for Preparedness and Response · HHSO100201700020C | $280M | Sep 21, 2017 | Sep 24, 2027 |
| IGF::OT::IGF Office of Assistant Secretary for Preparedness and Response · HHSO100201600023C | $8.6M | Aug 9, 2016 | Sep 30, 2022 |
Similar contractors
Companies winning under the same main NAICS code.
| Contractor | Awards | Obligated |
|---|---|---|
| Emergent Product Development Gaithersburg Inc. UEI CNPVCR8DK7M8 | 3 | $1.5B |
| Merck Sharp & Dohme LLC UEI FCFDA78HKKG2 | 3 | $310M |
| Dynport Vaccine Company LLC UEI LXNEGTYDR755 | 5 | $133M |
| Battelle Memorial Institute UEI F125YU6SWK59 | 20 | $99.4M |
| Fisher Bioservices Inc UEI LB4PCGLSJ9E6 | 3 | $95.1M |
| Sri International UEI SRG2J1WS9X63 | 11 | $59.4M |
Stop checking this page by hand
Matched, not listed
Describe your company once. Captivaq scores every new notice against your capabilities, locations, and set-asides.
Earlier than the RFP
Forecasts and sources sought notices surface months before the solicitation, while you can still shape the win.
A draft, not a link
For the bids worth pursuing, it reads the solicitation and drafts the response with citations back to the source.
Questions people ask
What is Regeneron Pharmaceuticals Inc's UEI?
N3F9MH7E6HD6. The Unique Entity ID is the 12-character number SAM.gov assigns to every company that registers to do business with the federal government. It replaced the DUNS number in 2022.
How much has Regeneron Pharmaceuticals Inc won in federal contracts?
$984M obligated across 3 awards in Captivaq's records, most of it from Office of Assistant Secretary for Preparedness and Response. That covers contracts of $1M or more active since October 2023, so the full history is larger.
Which Regeneron Pharmaceuticals Inc contracts end soon?
2 awards end in the next 18 months, listed on this page. Expiring contracts are often recompeted, which is the opening for a competitor or a teaming partner.
Figures come from federal award records published on USAspending.gov: contracts of $1M or more active since October 2023, plus smaller awards tied to open opportunities. They are not a complete contract history; each award above links to its official record.
Captivaq is an independent service from Logesta Labs LLC and is not affiliated with or endorsed by the U.S. government or SAM.gov. The notice on the official source portal is the record that governs; confirm deadlines and amendments there.